Supporting data for “Efficacy and Safety of Cs4, a Fermentation Product of Cordyceps sinensis (Berk) Sacc, on Alleviating Long COVID Symptoms: A Randomized Waitlist-Controlled Trial in Hong Kong”

These three documents are respectively the Baseline Characteristics of the participants, Outcomes after intervention or control, and Adverse Events during the study process. The Baseline Characteristics table presents the baseline characteristics, such as gender, age, height, weight, body mass index (BMI), number of COVID-19 vaccine doses, duration since the last infection, etc. The Outcomes table includes the raw data for primary and secondary outcomes. The Adverse Events table includes the raw data for blood tests.